We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$517B
AUM Growth
+$27.6B
Cap. Flow
-$8.37B
Cap. Flow %
-1.62%
Top 10 Hldgs %
19.4%
Holding
4,590
New
277
Increased
1,772
Reduced
2,129
Closed
201

Top Sells

Rank Stock Value
1
FERG icon
Ferguson
FERG
+$692M
2
LIN icon
Linde
LIN
+$624M
3
MDT icon
Medtronic
MDT
+$527M
4
GS icon
Goldman Sachs
GS
+$340M
5
MSFT icon
Microsoft
MSFT
+$301M

Sector Composition

Rank Sector Weight
1 Technology 25.25%
2 Healthcare 13.3%
3 Financials 12.53%
4 Consumer Discretionary 10.81%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCOR icon
3251
Comscore
SCOR
$93.7M
$1.26M ﹤0.01%
12,604
-2,179
-15% -$171K
WTTR icon
3252
Select Water Solutions
WTTR
$2.72B
$1.26M ﹤0.01%
208,593
-73,976
-26% -$427K
AWH
3253
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$1.25M ﹤0.01%
14,795
-268
-2% -$23K
GDRX icon
3254
GoodRx Holdings
GDRX
$1.25B
$1.25M ﹤0.01%
34,597
+10,124
+41% +$374K
RCEL icon
3255
Avita Medical
RCEL
$241M
$1.24M ﹤0.01%
60,434
+48,628
+412% +$958K
ACTG icon
3256
Acacia Research
ACTG
$451M
$1.24M ﹤0.01%
183,279
+361
+0.2% +$2.15K
CTMX icon
3257
CytomX Therapeutics
CTMX
$721M
$1.23M ﹤0.01%
194,496
-2,740
-1% -$21.3K
NESR
3258
National Energy Services Reunited Corp
NESR
$3.68B
$1.23M ﹤0.01%
86,396
+22,679
+36% +$305K
PVG
3259
DELISTED
PRETIUM RESOURCES INC.
PVG
$1.23M ﹤0.01%
+128,274
New +$1.4M
GWX icon
3260
State Street SPDR S&P International Small Cap ETF
GWX
$933M
$1.22M ﹤0.01%
31,663
-675
-2% -$26.2K
IQDG icon
3261
WisdomTree International Quality Dividend Growth Fund
IQDG
$733M
$1.22M ﹤0.01%
30,723
-12,843
-29% -$507K
SPRY icon
3262
ARS Pharmaceuticals
SPRY
$571M
$1.22M ﹤0.01%
39,544
+4,732
+14% +$152K
SKYY icon
3263
First Trust Cloud Computing ETF
SKYY
$3.3B
$1.22M ﹤0.01%
11,518
-141
-1% -$14.1K
FLXS icon
3264
Flexsteel Industries
FLXS
$303M
$1.22M ﹤0.01%
30,178
+16,435
+120% +$717K
CODX
3265
Co-Diagnostics
CODX
$5.27M
$1.22M ﹤0.01%
4,922
-263
-5% -$67.6K
DLTH icon
3266
Duluth Holdings
DLTH
$151M
$1.22M ﹤0.01%
58,950
-11,992
-17% -$198K
APLT
3267
DELISTED
Applied Therapeutics
APLT
$1.22M ﹤0.01%
58,508
-1,862
-3% -$35.2K
GRTS
3268
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$1.22M ﹤0.01%
133,112
+20,142
+18% +$186K
ATNX
3269
DELISTED
Athenex, Inc. Common Stock
ATNX
$1.21M ﹤0.01%
13,100
+526
+4% +$47.8K
SPYG icon
3270
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$55.4B
$1.21M ﹤0.01%
19,201
-330
-2% -$19.8K
BNFT
3271
DELISTED
Benefitfocus, Inc.
BNFT
$1.21M ﹤0.01%
85,581
-19,448
-19% -$274K
DEW icon
3272
WisdomTree Global High Dividend Fund
DEW
$157M
$1.2M ﹤0.01%
24,952
-10,049
-29% -$490K
TSHA icon
3273
Taysha Gene Therapies
TSHA
$1.87B
$1.2M ﹤0.01%
56,672
+29,740
+110% +$686K
DSKE
3274
DELISTED
Daseke, Inc. Common Stock
DSKE
$1.2M ﹤0.01%
185,093
+1,205
+0.7% +$8.75K
SURF
3275
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1.19M ﹤0.01%
159,297
+82,268
+107% +$634K

Similar funds

Bank of New York Mellon's Q2 2021 Portfolio in Review

As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
  • Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
  • Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
  • Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
  • Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
  • Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
  • Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.